EdgeTestMarket TodayOptions TodayIPO
Start free

SAIPARENTSai Parenterals Limited

Rs 455.65▼ -1.31%
Market closedEquity EOD 26 Oct
Compare
Range since listingThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.18.2% up the range
Rs 400Rs 706
SAIPARENT price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 26 Oct
IndicatorsVolume

Loading SAIPARENT price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 2,013 cr
Larger than 37% of 110 peers
sector middle Rs 4,734 cr
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
4.1x
Around the middle of 107 peers
sector middle 3.8x
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
3.6%
Lower than 80% of 105 peers
sector middle 14.9%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.65
Higher than 92% of 107 peers
sector middle 0.17
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.0%
Lower than 62% of 109 peers
sector middle 0.1%

Peers are the listed companies in the exchange's own industry group: Pharmaceuticals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 11 Aug 2026), sales was Rs 179 cr and profit was Rs 7.9 cr.

Nothing in the filings we hold crosses one of our rules yet. Each rule needs a few complete years of results, so recently listed companies often show nothing here.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 3 results, the share rose on 2 and fell on 1, and moved by 3% or more on 1.

Q3 FY26Q1 FY27

Q1 FY27: results filed 11 Aug 2026. The share went from its close on 10 Aug 2026 to its close on 12 Aug 2026 -5.97%.

Fundamentals
Trailing-twelve-month valuation, margins and growth from the company's own filings.

We do not have quarterly financials for SAIPARENT yet. Some companies, mainly insurers, file in a format we cannot read at the moment. Everything else on this page is current.

What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 1,424 Cr of assets. Its owners funded 35% of that and borrowings 22%.

What it owns
19%
12%
12%
13%
29%
15%
Plant, property and projects274 Cr
Goodwill and intangibles173 Cr
Inventory172 Cr
Owed by customers181 Cr
Cash and bank417 Cr
Everything else208 Cr
How that is paid for
35%
22%
10%
32%
Shareholders495 Cr
Borrowings319 Cr
Owed to suppliers149 Cr
Other liabilities461 Cr
Cash and equivalents
Rs 417 Cr
Net debt
Rs -97 Cr
more cash than debt
Current ratio
1.44x
short-term assets per rupee due soon
Book value / share
Rs 111
EV / EBITDA
40.6x

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs 93 Cr, spent Rs 18 Cr on plant and equipment, and cash rose by Rs 415 Cr over the year.

From running the business
+93 Cr
Spent on or received from investing
-274 Cr
From or to lenders and shareholders
+596 Cr
Net change in cash
+415 Cr

Full financial year to 2026-03-31, from the company's cash flow statement.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
3 quarters
RevenueRs 179 Cr
Net profitRs 8 Cr
Dec 253 quarters filedJun 26

Each bar is one quarter as filed with the exchange, newest on the right, so the seasonal shape of the business is visible rather than smoothed away. Hover any quarter for its full figures and the change against the same quarter a year earlier. Revenue and profit are drawn on separate scales because they differ by an order of magnitude; reading one against the other would be misleading.

Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 26 Oct
RSI (14) - momentum
33.6Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
44.2%Near average
today 44.2%20d avg 54%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-11.17%
vs 200-DMA
-
1-month
-10.53%
3-month
-14.93%
1-year
-
Realized vol (30d)
36.2%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on SAIPARENT?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.